| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 64,056 | 65,054 | 62,996 | 54,312 | | Cost of Revenue | 23,979 | 23,587 | 23,363 | 22,113 | | | Gross Profit | 40,077 | 41,467 | 39,633 | 32,199 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,106 | 5,329 | 6,967 | 5,588 | | Non Recurring | 429 |
-
|
-
|
-
| | Others | 16,581 | 17,020 | 17,669 | 14,958 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,961 | 19,118 | 14,997 | 11,653 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,418 | 228 | 2,856 | 3,711 | | Earnings Before Interest And Taxes | 18,253 | 19,361 | 17,838 | 15,364 | | Interest Expense | 9,587 | 10,042 | 10,074 | 9,747 | | Income Before Tax | 8,666 | 9,319 | 7,764 | 5,617 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
| 15 | (15) |
-
| | | | Net Income From Continuing Ops | 8,666 | 9,319 | 7,764 | 5,617 | | | Non-recurring Events | | Discontinued Operations | 373 | 7,510 | 13,101 | 9,982 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,027 | 16,829 | 20,865 | 15,599 | | Preferred Stock And Other Adjustments | 77 | (77) |
-
|
-
| | | Net Income Applicable To Common Shares | $9,104 | $16,752 | $20,865 | $15,599 |
|
0.15% Nasdaq 
0.28%
Income Statement
